Shanghai Kaibao Pharmaceutical (300039.SZ) controlling shareholder, actual controller and some directors, executives plan to increase their holdings in the company.

Shanghai Kaibao Pharmaceutical (300039.SZ) announced that the company has recently received notification from the company's controlling shareholder, actual controller, and some directors and senior management personnel (referred to as the "increasing holding entity" below), regarding their intention to increase their holdings of the company's shares through centralized competitive trading within 6 months from the date of this announcement. The total amount of the increase plan shall not be less than RMB 1.5 million, based on their recognition of the company's intrinsic value and their firm confidence in the future continued stable and healthy development, as well as the desire to maintain shareholder interests and enhance investor confidence.